Last reviewed · How we verify
Intra-articular platelet-rich plasma — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Intra-articular platelet-rich plasma (Intra-articular platelet-rich plasma) — King Hamad University Hospital, Bahrain.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Intra-articular platelet-rich plasma TARGET | Intra-articular platelet-rich plasma | King Hamad University Hospital, Bahrain | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Intra-articular platelet-rich plasma CI watch — RSS
- Intra-articular platelet-rich plasma CI watch — Atom
- Intra-articular platelet-rich plasma CI watch — JSON
- Intra-articular platelet-rich plasma alone — RSS
Cite this brief
Drug Landscape (2026). Intra-articular platelet-rich plasma — Competitive Intelligence Brief. https://druglandscape.com/ci/intra-articular-platelet-rich-plasma. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab